Nanobody-based trispecific T cell engager (Nb-TriTE) enhances therapeutic efficacy by overcoming tumor-mediated immunosuppression
Ziqiang Ding(Guangxi Medical University), Xiaoling Lü(Guangxi Medical University), Shenxia Xie(Guangxi Medical University), Fengzhen Mo(Stomatology Hospital), Wei Shi(Guangxi University), Shuyang Sun(Guangxi Medical University), Xuan Wang(Union Hospital), Xiaobing Jiang(Union Hospital), Xiaomei Yang(University of Maryland, Baltimore), Zhuoran Tang(Guangxi Medical University), Aiqun Liu(Guangxi Medical University), Xianing Huang, Xiaoqiong Hou(Stomatology Hospital)
Cited by 30
Related Papers
High salt primes a specific activation state of macrophages, M(Na)
|Cell Research|2015|243
Nanomaterials for Cancer Precision Medicine
|Advanced Materials|2018|212
T Cell Ig Mucin-3 Promotes Homeostasis of Sepsis by Negatively Regulating the TLR Response
|The Journal of Immunology|2013|142
Nanobody: A Small Antibody with Big Implications for Tumor Therapeutic Strategy
|International Journal of Nanomedicine|2021|141